(Q50745621)

18 March 2018

title

Donepezil in Parkinson's disease dementia: a randomized, double-blind efficacy and safety study. (English)

1 reference

18 March 2018

Parkinson's disease dementia

1 reference

1 reference

2

Eduardo Tolosa

1 reference

18 March 2018

5

Andrew J Lees

1 reference

18 March 2018

Regina Katzenschlager

3

object named as

Regina Katzenschlager

1 reference

18 March 2018

Bruno Dubois

1

1 reference

18 March 2018

Murat Emre

4

1 reference

18 March 2018

Günther Schumann

6

1 reference

18 March 2018

Emmanuelle Pourcher

7

1 reference

18 March 2018

Julian Gray

8

1 reference

18 March 2018

Gail Thomas

9

1 reference

18 March 2018

Jina Swartz

10

1 reference

18 March 2018

Timothy Hsu

11

1 reference

18 March 2018

Margaret L Moline

12

1 reference

18 March 2018

language of work or name

English

0 references

publication date

22 August 2012

1 reference

18 March 2018

published in

Movement Disorders

1 reference

18 March 2018

volume

27

1 reference

18 March 2018

issue

10

1 reference

18 March 2018

page(s)

1230-1238

1 reference

18 March 2018

An Essay on the Shaking Palsy

cites work

1 reference

Dementia and survival in Parkinson disease: a 12-year population study.

21 January 2018

1 reference

Evolution of cognitive dysfunction in an incident Parkinson's disease cohort.

21 January 2018

1 reference

Alpha-synuclein-immunoreactive cortical Lewy bodies are associated with cognitive impairment in Parkinson's disease.

21 January 2018

1 reference

Relationships between age and late progression of Parkinson's disease: a clinico-pathological study.

21 January 2018

1 reference

High-speed memory scanning in Parkinson's disease: adverse effects of levodopa.

21 January 2018

1 reference

A subcortico-cortical cholinergic system is affected in Parkinson's disease.

21 January 2018

1 reference

Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.

21 January 2018

1 reference

Neurotransmitter changes in dementia with Lewy bodies and Parkinson disease dementia in vivo

21 January 2018

1 reference

Rivastigmine in the treatment of parkinsonian psychosis and cognitive impairment: preliminary findings from an open trial

21 January 2018

1 reference

Cognitive, psychiatric and motor response to galantamine in Parkinson's disease with dementia

21 January 2018

1 reference

Rivastigmine for dementia associated with Parkinson's disease

21 January 2018

1 reference

Donepezil for dementia in Parkinson's disease: a randomised, double blind, placebo controlled, crossover study

21 January 2018

1 reference

Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases

21 January 2018

1 reference

21 January 2018

1 reference

Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop

21 January 2018

1 reference

A new rating scale for Alzheimer's disease.

21 January 2018

1 reference

Development of a functional measure for persons with Alzheimer's disease: the disability assessment for dementia.

21 January 2018

1 reference

Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials

21 January 2018

1 reference

Cholinergic deficiency and frontal dysfunction in Parkinson's disease

21 January 2018

1 reference

Current treatment of dementia with Lewy bodies and dementia associated with Parkinson's disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/MDS.25098

1 reference

18 March 2018

1 reference

18 March 2018